Zobrazeno 1 - 10
of 36
pro vyhledávání: '"Keita Hamamatsu"'
Autor:
Takaaki Murakami, Hiroyuki Fujimoto, Keita Hamamatsu, Yuki Yamauchi, Yuzo Kodama, Naotaka Fujita, Junji Fujikura, Yoichi Shimizu, Yuji Nakamoto, Hiroyuki Kimura, Hideo Saji, Nobuya Inagaki
Publikováno v:
Scientific Reports, Vol 11, Iss 1, Pp 1-12 (2021)
Abstract Specifying the exact localization of insulinoma remains challenging due to the lack of insulinoma-specific imaging methods. Recently, glucagon-like peptide-1 receptor (GLP-1R)-targeted imaging, especially positron emission tomography (PET),
Externí odkaz:
https://doaj.org/article/eb79b0bd544f428e86385fa7f2a8e030
Autor:
Sakura Kiyobayashi, Takaaki Murakami, Norio Harada, Hiroyuki Fujimoto, Yuki Murata, Naotaka Fujita, Keita Hamamatsu, Eri Ikeguchi-Ogura, Tomonobu Hatoko, Xuejing Lu, Shunsuke Yamane, Nobuya Inagaki
Publikováno v:
Frontiers in Endocrinology, Vol 13 (2022)
Pancreatic β-cell mass (BCM) has an importance in the pathophysiology of diabetes mellitus. Recently, glucagon-like peptide-1 receptor (GLP-1R)-targeted imaging has emerged as a promising tool for BCM evaluation. While glucose-dependent insulinotrop
Externí odkaz:
https://doaj.org/article/56eb90921da74ff78c9ad91627258319
Autor:
Takaaki Murakami, Hiroyuki Fujimoto, Naotaka Fujita, Keita Hamamatsu, Daisuke Yabe, Nobuya Inagaki
Publikováno v:
Journal of Diabetes Investigation, Vol 11, Iss 6, Pp 1448-1456 (2020)
Abstract Aims/Introduction Glucagon‐like peptide‐1 receptor agonists (GLP‐1RA) are used for treatment of type 2 diabetes mellitus worldwide. However, some patients do not respond well to the therapy, and caution must be taken for certain patien
Externí odkaz:
https://doaj.org/article/d7fd8932caa541b98905c6d9bcf1681a
Autor:
Hiroyuki Fujimoto, Naotaka Fujita, Keita Hamamatsu, Takaaki Murakami, Yuji Nakamoto, Tsuneo Saga, Takayoshi Ishimori, Yoichi Shimizu, Hiroyuki Watanabe, Kohei Sano, Norio Harada, Hiroshi Nakamura, Kentaro Toyoda, Hiroyuki Kimura, Shunsaku Nakagawa, Mitsuharu Hirai, Atsushi Murakami, Masahiro Ono, Kaori Togashi, Hideo Saji, Nobuya Inagaki
Publikováno v:
Frontiers in Endocrinology, Vol 12 (2021)
Pancreatic β-cell mass (BCM) has a central importance in the pathophysiology of diabetes mellitus. Recently, pancreatic β-cell-specific imaging, especially positron emission tomography (PET) with exendin-based probes, has emerged for non-invasive e
Externí odkaz:
https://doaj.org/article/d3b5de91dba247f7b39b785890233ef5
Autor:
Yuji Nakamoto, Hiroyuki Kimura, Junji Fujikura, Keita Hamamatsu, Naotaka Fujita, Hiroyuki Fujimoto, Yuki Yamauchi, Takaaki Murakami, Hideo Saji, Yuzo Kodama, Nobuya Inagaki, Yoichi Shimizu
Publikováno v:
Scientific Reports, Vol 11, Iss 1, Pp 1-12 (2021)
Specifying the exact localization of insulinoma remains challenging due to the lack of insulinoma-specific imaging methods. Recently, glucagon-like peptide-1 receptor (GLP-1R)-targeted imaging, especially positron emission tomography (PET), has emerg
Autor:
Keita Hamamatsu, Nobuya Inagaki, Hiroyuki Fujimoto, Daisuke Yabe, Takaaki Murakami, Naotaka Fujita
Publikováno v:
Journal of Diabetes Investigation, Vol 11, Iss 6, Pp 1448-1456 (2020)
Journal of Diabetes Investigation
Journal of Diabetes Investigation
Aims/Introduction Glucagon‐like peptide‐1 receptor agonists (GLP‐1RA) are used for treatment of type 2 diabetes mellitus worldwide. However, some patients do not respond well to the therapy, and caution must be taken for certain patients, inclu
Autor:
Naotaka Fujita, Norio Harada, Masahiro Ono, Hideo Saji, Hiroyuki Watanabe, Kohei Sano, Keita Hamamatsu, Nobuya Inagaki, Tsuneo Saga, Atsushi Murakami, Mitsuharu Hirai, Yoichi Shimizu, Kaori Togashi, Takaaki Murakami, Takayoshi Ishimori, Hiroyuki Kimura, Shunsaku Nakagawa, Hiroshi Nakamura, Hiroyuki Fujimoto, Yuji Nakamoto, Kentaro Toyoda
Publikováno v:
Frontiers in Endocrinology
Frontiers in Endocrinology, Vol 12 (2021)
Frontiers in Endocrinology, Vol 12 (2021)
Pancreatic β-cell mass (BCM) has a central importance in the pathophysiology of diabetes mellitus. Recently, pancreatic β-cell-specific imaging, especially positron emission tomography (PET) with exendin-based probes, has emerged for non-invasive e
Autor:
Hiroyuki Fujimoto, Hideo Saji, Hiroyuki Kimura, Nobuya Inagaki, Takaaki Murakami, Kentaro Toyoda, Keita Hamamatsu, Naotaka Fujita
Publikováno v:
The FASEB Journal. 33:11836-11844
Currently, quantifying β-cell mass (BCM) requires harvesting the pancreas. In this study, we investigated a potential noninvasive method to quantify BCM changes longitudinally using [Lys12(111In-BnDTPA-Ahx)]exendin-4 ([111In]-Ex4) and single-photon
Autor:
Takaaki, Murakami, Hiroyuki, Fujimoto, Keita, Hamamatsu, Yuki, Yamauchi, Yuzo, Kodama, Naotaka, Fujita, Junji, Fujikura, Yoichi, Shimizu, Yuji, Nakamoto, Hiroyuki, Kimura, Hideo, Saji, Nobuya, Inagaki
Publikováno v:
Scientific Reports
Specifying the exact localization of insulinoma remains challenging due to the lack of insulinoma-specific imaging methods. Recently, glucagon-like peptide-1 receptor (GLP-1R)-targeted imaging, especially positron emission tomography (PET), has emerg
Autor:
Takaaki Murakami, Hiroyuki Fujimoto, Naotaka Fujita, Keita Hamamatsu, Hiroyuki Kimura, Hideo Saji, Nobuya Inagaki
Publikováno v:
Nuclear Medicine and Biology. :22-27
Introduction Radiolabeled exendin derivatives have been developed to visualize and quantify pancreatic beta cells. However, there are currently no established methods for analyzing in-vivo SPECT/CT images to quantify probe accumulation in the pancrea